Jan. 22 at 10:21 PM
$PLNH
Excerpts from new report
The build out of the Florida BHO extraction lab, with management expecting concentrates and extracts on shelves around early 2026, broadens the product set in a large medical market and is positioned to support higher basket sizes and improved gross margin mix as more value added products are sold.
Cultivation upgrades in Florida that management says are driving better yield, potency and consistency, combined with improved post harvest processing and packaging, are set up to support higher quality flower at lower unit costs. This can feed through to gross margin and potentially lift earnings if volume scales.
The exit from California, which management expects to remove roughly US
$300,000 to US
$350,000 a month of cash flow drag once fully closed, simplifies operations and can support higher consolidated margins and a clearer path toward EBITDA improvement.
The Las Vegas SuperStore event program, including concerts, pregame shows and use of the new plaza